Table 2.
MAP kinase inhibitors and their effect in various models of tissue injury
Pathway | Inhibitor | Effect | Reference |
---|---|---|---|
ERK1/2 | PD98059 | ↓ CSE induced MMP-1 (in vitro) | Mercer et al 2004 |
↓ LPS-induced neutrophilia, cell death, airway leakage | Lee et al 2004 | ||
↓ Airway epithelial thickening | Tamaoki et al 2004 | ||
CI-1040 | ↓ Adenoma proliferation ←→ Apoptosis | Kramer et al 2004 | |
UO126 | ↓ Lung inflammation | Chialda et al 2005 | |
p38 | SB230580 | ↓ LPS-induced MIP2, TNFα, neutrophilia | Arcaroli et al 2004 |
SB239063 | ↓ LPS-induced IL-6 expression (in vitro) | Underwood et al 2000 | |
↓ LPS-induced fibrosis, MMP-9 expression, neutrophilia | Underwood et al 2000 | ||
SAPK/JNK | SP600125 | ↓ Lung inflammation | Chialda et al 2005 |
↓ Arthritic joint swelling, collagenase expression | Han et al 2001 | ||
CEP-1347 | ↓ Neuronal apoptosis | Maroney et al 1998 | |
↓ Pancreatic edema, inflammation | Wagner et al 2000 |